By Lebone Rodah Mosima Durban-born researcher Dr Sahil Tulsi has provided important new insights into how genetic differences among South Africans may influence responses to TB treatment. Tulsi, who earned his Doctor of Philosophy in Virology from the University of KwaZulu-Natal, examined how genetic variation affects the way patients process anti-TB medication in his study, Influence of Drug Transporter Gene Polymorphisms on Pharmacogenetic and…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.